Carbonic Anhydrase XII As an Independent Prognostic Factor in Advanced Esophageal Squamous Cell Carcinoma

Overview

Journal J Cancer

Specialty Oncology

Date 2015 Aug 29

PMID 26316888

Citations 12

Authors

Fumiaki Ochi

Atsushi Shiozaki

Daisuke Ichikawa

Hitoshi Fujiwara

Shingo Nakashima

Kenichi Takemoto

Toshiyuki Kosuga

Hirotaka Konishi

Shuhei Komatsu

Kazuma Okamoto

Mitsuo Kishimoto

Yoshinori Marunaka

Eigo Otsuji

Affiliations

Soon will be listed here.

Abstract

Background: Although recent studies described important roles for carbonic anhydrase (CA) XII in epithelial carcinogenesis and tumor behavior, a consensus has not yet been reached regarding its clinicopathological significance in esophageal squamous cell carcinoma (ESCC). In the present study, we investigated its prognostic significance in ESCC.

Materials And Methods: An immunohistochemical analysis was performed on 70 primary tumor samples obtained from ESCC patients who underwent esophagectomy, and the relationships between the expression of CA XII and various clinicopathological features or prognosis were analyzed.

Results: Immunohistochemical staining showed that CA XII was primarily found in the cell membranes of carcinoma cells. Although the expression of CA XII was related to the pT category, it had no prognostic impact. We then examined the expression of CA XII according to the pT category. In pT2-3 ESCC, the 3-year survival rate of patients with the high grade expression of CA XII (29.1 %) was significantly lower than that of patients with the low grade expression of CA XII (70.3 %). Furthermore, a multivariate analysis demonstrated that the expression of CA XII was one of the most important independent prognostic factors following radical esophagectomy in pT2-3 ESCC.

Conclusion: These results suggest that the expression of CA XII may be a valuable prognostic factor for patients with advanced ESCC. The results of the present study provide an insight into the role of CA XII as a biomarker in ESCC.

Citing Articles

Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance.

Krymov S, Scherbakov A, Dezhenkova L, Salnikova D, Soloveva S, Sorokin D Pharmaceuticals (Basel). 2022; 15(12).

PMID: 36558903 PMC: 9783868. DOI: 10.3390/ph15121453.

Drug repositioning for esophageal squamous cell carcinoma.

Bennett A, Huang R, He Q, Lee N, Sung W, Katie Chan K Front Genet. 2022; 13:991842.

PMID: 36246638 PMC: 9554346. DOI: 10.3389/fgene.2022.991842.

Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma.

Nortunen M, Parkkila S, Saarnio J, Huhta H, Karttunen T J Histochem Cytochem. 2021; 69(11):677-690.

PMID: 34636283 PMC: 8554582. DOI: 10.1369/00221554211050133.

Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma.

Gu X, Shi C, Zhao W Int J Clin Exp Pathol. 2020; 12(6):2173-2183.

PMID: 31934040 PMC: 6949632.

Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.

Wang Y, Li H, Ma J, Fang T, Li X, Liu J Onco Targets Ther. 2019; 12:8401-8410.

PMID: 31632087 PMC: 6792947. DOI: 10.2147/OTT.S215898.

References

Driessen A, Landuyt W, Pastorekova S, Moons J, Goethals L, Haustermans K . Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas. Ann Surg. 2006; 243(3):334-40. PMC: 1448952. DOI: 10.1097/01.sla.0000201452.09591.f3. View

Hynninen P, Vaskivuo L, Saarnio J, Haapasalo H, Kivela J, Pastorekova S . Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours. Histopathology. 2006; 49(6):594-602. DOI: 10.1111/j.1365-2559.2006.02523.x. View

Potter C, Harris A . Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer. 2003; 89(1):2-7. PMC: 2394207. DOI: 10.1038/sj.bjc.6600936. View

Shimizu H, Shiozaki A, Ichikawa D, Fujiwara H, Konishi H, Ishii H . The expression and role of Aquaporin 5 in esophageal squamous cell carcinoma. J Gastroenterol. 2013; 49(4):655-66. DOI: 10.1007/s00535-013-0827-9. View

Ilie M, Hofman V, Zangari J, Chiche J, Mouroux J, Mazure N . Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients. Lung Cancer. 2013; 82(1):16-23. DOI: 10.1016/j.lungcan.2013.07.005. View

Pouyssegur J, Dayan F, Mazure N . Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature. 2006; 441(7092):437-43. DOI: 10.1038/nature04871. View

Buanne P, Renzone G, Monteleone F, Vitale M, Monti S, Sandomenico A . Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells. J Proteome Res. 2012; 12(1):282-92. DOI: 10.1021/pr300565w. View

Chien M, Ying T, Hsieh Y, Lin C, Shih C, Wei L . Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis. Oral Oncol. 2011; 48(5):417-23. DOI: 10.1016/j.oraloncology.2011.11.015. View

Tanaka N, Kato H, Inose T, Kimura H, Faried A, Sohda M . Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer. 2008; 99(9):1468-75. PMC: 2579701. DOI: 10.1038/sj.bjc.6604719. View

10.

Jomrich G, Jesch B, Birner P, Schwameis K, Paireder M, Asari R . Stromal expression of carbonic anhydrase IX in esophageal cancer. Clin Transl Oncol. 2014; 16(11):966-72. DOI: 10.1007/s12094-014-1180-z. View

11.

Shiozaki A, Nako Y, Ichikawa D, Konishi H, Komatsu S, Kubota T . Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma. World J Gastroenterol. 2014; 20(22):6844-59. PMC: 4051924. DOI: 10.3748/wjg.v20.i22.6844. View

12.

Chao A, Wang T, Lai C . Overview of microarray analysis of gene expression and its applications to cervical cancer investigation. Taiwan J Obstet Gynecol. 2008; 46(4):363-73. PMC: 7129792. DOI: 10.1016/S1028-4559(08)60005-4. View

13.

Haapasalo J, Hilvo M, Nordfors K, Haapasalo H, Parkkila S, Hyrskyluoto A . Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas. Neuro Oncol. 2008; 10(2):131-8. PMC: 2613815. DOI: 10.1215/15228517-2007-065. View

14.

Watson P, Chia S, Wykoff C, Han C, Leek R, Sly W . Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer. 2003; 88(7):1065-70. PMC: 2376369. DOI: 10.1038/sj.bjc.6600796. View

15.

Remmele W, Stegner H . [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe. 1987; 8(3):138-40. View

16.

Iitaka D, Shiozaki A, Ichikawa D, Kosuga T, Komatsu S, Okamoto K . Blockade of chloride ion transport enhances the cytocidal effect of hypotonic solution in gastric cancer cells. J Surg Res. 2012; 176(2):524-34. DOI: 10.1016/j.jss.2011.10.039. View

17.

Proescholdt M, Mayer C, Kubitza M, Schubert T, Liao S, Stanbridge E . Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol. 2005; 7(4):465-75. PMC: 1871734. DOI: 10.1215/S1152851705000025. View

18.

Birner P, Jesch B, Friedrich J, Riegler M, Zacherl J, Hejna M . Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Ann Surg Oncol. 2011; 18(12):3330-7. DOI: 10.1245/s10434-011-1730-3. View

19.

Shiozaki A, Takemoto K, Ichikawa D, Fujiwara H, Konishi H, Kosuga T . The K-Cl cotransporter KCC3 as an independent prognostic factor in human esophageal squamous cell carcinoma. Biomed Res Int. 2014; 2014:936401. PMC: 4119626. DOI: 10.1155/2014/936401. View

20.

Harima Y, Togashi A, Horikoshi K, Imamura M, Sougawa M, Sawada S . Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys. 2004; 60(1):237-48. DOI: 10.1016/j.ijrobp.2004.02.047. View